Technical Analysis for ABIO - ARCA biopharma, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
6.43 | 5.76% | 0.35 |
ABIO closed up 5.76 percent on Monday, September 16, 2019, on 56 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Earnings due: Sep 27
*** please verify all earnings dates ***| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| See historical ABIO trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 50 DMA | Bullish | 0.00% | |
| MACD Bullish Centerline Cross | Bullish | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| 50 DMA Resistance | Bearish | 5.76% | |
| Calm After Storm | Range Contraction | 5.76% | |
| Upper Bollinger Band Walk | Strength | 5.76% | |
| Inside Day | Range Contraction | 5.76% | |
| Upper Bollinger Band Touch | Strength | 5.76% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
- Sector: Healthcare
- Industry: Biotechnology
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Broomfield, Colorado.
Biopharmaceutical Anatomy Cardiovascular Diseases Heart Failure Atrial Fibrillation Cardiac Arrhythmia Heart Diseases Ventricular Dysfunction
Biopharmaceutical Anatomy Cardiovascular Diseases Heart Failure Atrial Fibrillation Cardiac Arrhythmia Heart Diseases Ventricular Dysfunction
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more ABIO news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 20.4499 |
| 52 Week Low | 4.68 |
| Average Volume | 98,251 |
| 200-Day Moving Average | 7.1752 |
| 50-Day Moving Average | 6.1715 |
| 20-Day Moving Average | 5.5963 |
| 10-Day Moving Average | 5.76 |
| Average True Range | 0.504 |
| ADX | 22.43 |
| +DI | 33.409 |
| -DI | 12.166 |
| Chandelier Exit (Long, 3 ATRs ) | 5.9231 |
| Chandelier Exit (Short, 3 ATRs ) | 6.402 |
| Upper Bollinger Band | 6.4048 |
| Lower Bollinger Band | 4.7878 |
| Percent B (%b) | 1.02 |
| BandWidth | 28.894091 |
| MACD Line | 0.023 |
| MACD Signal Line | -0.132 |
| MACD Histogram | 0.155 |
| Fundamentals | Value |
|---|---|
| Market Cap | 75.53 Million |
| Num Shares | 11.7 Million |
| EPS | -2.05 |
| Price-to-Earnings (P/E) Ratio | -3.14 |
| Price-to-Sales | 0.00 |
| Price-to-Book | 0.92 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.11 | ||||
| Resistance 3 (R3) | 7.04 | 6.76 | 6.99 | ||
| Resistance 2 (R2) | 6.76 | 6.58 | 6.79 | 6.95 | |
| Resistance 1 (R1) | 6.59 | 6.48 | 6.68 | 6.66 | 6.92 |
| Pivot Point | 6.31 | 6.31 | 6.35 | 6.34 | 6.31 |
| Support 1 (S1) | 6.14 | 6.13 | 6.23 | 6.21 | 5.94 |
| Support 2 (S2) | 5.86 | 6.03 | 5.89 | 5.91 | |
| Support 3 (S3) | 5.69 | 5.86 | 5.87 | ||
| Support 4 (S4) | 5.76 |
